Alberta Investment Management Corp (AIMCo)’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-7,323
Closed -$4.11M 835
2020
Q4
$4.11M Sell
7,323
-1,075
-13% -$681K 0.04% 416
2020
Q3
$5.87M Hold
8,398
0.06% 337
2020
Q2
$6.64M Buy
8,398
+1,339
+19% +$1.01M 0.08% 289
2020
Q1
$4.2M Buy
7,059
+1,318
+23% +$1.28M 0.07% 291
2019
Q4
$6.53M Buy
5,741
+1,932
+51% +$2.1M 0.06% 304
2019
Q3
$4.53M Buy
3,809
+1,961
+106% +$2.99M 0.04% 357
2019
Q2
$3.04M Buy
+1,848
New +$3.2M 0.03% 421

Other funds holding BLUE

Alberta Investment Management Corp (AIMCo)'s BLUE Position: Q1 2021 in Review

Alberta Investment Management Corp (AIMCo) sold out of bluebird bio (BLUE) in Q1 2021, closing a stake of 7,323 shares — an estimated $4.11M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in BLUE in Q2 2019 and held it in 7 quarters. The position peaked at $6.64M in Q2 2020. 229 funds tracked by Wall St. Rank hold BLUE as of Q1 2021.

  • Alberta Investment Management Corp (AIMCo) reported no remaining bluebird bio position as of Q1 2021 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 7,323 bluebird bio shares in Q1 2021, an estimated $4.11M.
  • Alberta Investment Management Corp (AIMCo) first reported a position in bluebird bio in Q2 2019 and held it in 7 quarters.
  • Alberta Investment Management Corp (AIMCo)'s bluebird bio position peaked at $6.64M in Q2 2020.
  • 229 funds tracked by Wall St. Rank held bluebird bio as of Q1 2021.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2021, filed 7 May 2021.